# OpenAI to acquire Orchestra Bio

> OpenAI says it will buy Orchestra Bio to add AI tools for drug research.

Oossa · 2026-10-20 · https://oossa.com/en/openai-to-acquire-orchestra-bio

OpenAI announced it will acquire Orchestra Bio. The deal aims to put AI into life‑science research labs. OpenAI says the move will help biopharma teams speed up drug development and create new treatments. No financial terms were disclosed.

## The facts

- OpenAI announced the acquisition on Oct 20, 2026.
- The target company is Orchestra Bio, a life‑science AI startup.

## Why it matters

Biotech firms could use OpenAI’s models to cut the time needed to test drug candidates.

## Sources & references

1. [OpenAI acquires Orchestra Bio](https://openai.com/index/openai-to-acquire-orchestra-bio) – OpenAI, 2026-10-20
2. [OpenAI acquires Orchestra Bio to bring AI agents into drug development](https://siliconangle.com/2026/10/20/openai-acquires-orchestra-bio-to-bring-ai-agents-into-drug-development/) – SiliconANGLE, 2026-10-20
3. [OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business](https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%e2%81%a0-to-beef-up-its-biotech-business/) – TechCrunch, 2026-10-20
4. [OpenAI acquires Orchestra Bio to build AI agents that speed up drug development](https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/) – The Decoder, 2026-10-21
5. [OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer](https://www.wired.com/story/openai-startup-brain-implants-detect-cancer/) – Wired, 2026-10-21

Last updated: 2026-10-21